Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam XR for very heavy drinkers with alcohol dependence
NCT00970814Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Oct 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levetiracetam in alcohol dependence, sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoints: Percentage of Subjects With no Heavy Drinking Days at 14 weeks and Percentage of Heavy Drinking Days Per Week at 14 weeks. Started Oct 2009; status: completed.
02
Drugs
levetiracetam
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00970814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970814.